Тип публикации: статья из журнала

Год издания: 2009

Идентификатор DOI: 10.1007/s10517-010-0748-z

Ключевые слова: Anaferon (pediatric formulation), Erythron, Poetam, Posthemorrhagic iron-defi cient anemia, Pubertal uterine bleedings, anaferon, antianemic agent, ferrous sulfate, hematologic agent, iron, lipoprotein, sorbifer, thiol derivative, unclassified drug, adolescent, adult, article, clinical trial, controlled clinical trial, controlled study, dose response, drug effect, drug efficacy, drug synthesis, erythrocyte membrane, erythrocyte metabolism, erythrocyte structure, female, human, iron deficiency anemia, low drug dose, major clinical study, metabolism, tablet, uterus bleeding, Anemia, Iron-Deficiency, Antibodies, Dose-Response Relationship, Drug, Humans, Uterine Hemorrhage

Аннотация: Poetam and anaferon (pediatric formulation) administered in combination with iron preparation to patients with anemia induce pronounced positive shifts in metabolic and morphological status of mature erythrocytes: the number of sulfhydryl groups and lipoprotein complexes in cell membranes and dry weight of erythrocytes increased, wПоказать полностьюhile the number of forms at different stages of degeneration decreased. © 2009 Springer Science+Business Media, Inc.

Журнал: Bulletin of Experimental Biology and Medicine

Выпуск журнала: Vol. 148, Is. 3

Номера страниц: 505-507

• Sotnikova L.S. (Siberian Division, Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk, Russian Federation, Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk, Russian Federation)
• Shevtsova N.M. (Siberian Division, Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk, Russian Federation, Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk, Russian Federation)
• Sherstoboev E.Yu. (Siberian Division, Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk, Russian Federation, Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk, Russian Federation)
• Zhdanov V.V. (Siberian Division, Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk, Russian Federation, Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk, Russian Federation)
• Dygai A.M. (Siberian Division, Institute of Pharmacology, Russian Academy of Medical Sciences, Tomsk, Russian Federation, Siberian State Medical University, Federal Agency for Health Care and Social Development, Tomsk, Russian Federation)

• Scopus